Hematological malignancies

FASEB Journal

Volumn 11, Issue 8, 1997, Pages 640-648

  Brenner, Malcolm K ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Bone marrow transplantation; Gene therapy; Gene transfer; Hemopoietic stem cell; Tumor vaccine

Indexed keywords

CANCER GENETICS; CANCER THERAPY; CYTOTOXIC T LYMPHOCYTE; GENE THERAPY; GENETIC DISORDER; HEMATOLOGIC DISEASE; HUMAN; LEUKEMIA; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0030802430     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.11.8.9240966     Document Type: Review

References (39)

1. Miller, A. D. (1992) Human gene therapy comes of age. Nature (London) 357, 455-460
2. Dilloo, D., Rill, D., Entwistle, C., Boursnell, M., Zhong, W., Holden, W., Holladay, M., Inglis, S., and Brenner, M. (1996) A novel herpes vector for the high efficiency transduction of normal and malignant human hemopoietic cells. Blood in press
3. Rossi, J. J. (1995) Therapeutic antisense and ribozymes. Br. Med. Bull. 51, 217-225
4. Zhang, Y., Mukhopadhyay, T., Donehower, L. A., Georges, R. N., and Roth, J. A. (1993) Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype. Human Gene Ther. 4, 451-460
5. Fujiwara, T., Grimm, E. A., Cai, D. W., Owen-Schaub, L. B., and Roth, J. A. (1993) A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Cancer Res. 53, 4129-4133
6. Wang, J., Bucana, C. D., Roth, J. A., and Zhang, W. (1995) Apoptosis induced in human osteosarcoma cells is one of the mechanisms for the cytocidal effect of Ad5CMV-p53. Cancer Gene Ther. 2, 9-18
7. Culver, K. W., Ram, Z., Wallbridge, S., Ishii, H., Oldfield, E. H., and Blaese, R. M. (1992) In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552
8. Bi, W. L., Parysek, L. M., Warnick, R., and Stambrook, P. J. (1993) In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV Tk retroviral gene therapy. Human Genf Ther. 4, 725-732
9. Freeman, S. M., Abboud, C. N., Whartenby, K. A., Packman, C. H., Koeplin, D. S., Moolten, F. L., and Abraham, G. N. (1993) The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53, 5274-5283
10. Huber, B. E., Austin, E. A., Richards, C. A., Davis, S. T., and Good, S. S. (1994) Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminse. Proc. Natl. Acad. Sci. USA 91, 8302-8306
11. Wei, M. X., Tamiya, T., Chase, M., Boviatsis, E. J., Chang, T. K., Kowall, N. W., Hockberg, F. H., Waxman, D. J., Breakefield, X. O., and Chiocca, E. A. (1994) Experimental tumor therapy in mice using the cyclophosphamide-activating cytochrome P450 2B1 gene. Human Gene Ther. 5, 969-978
12. Knox, R. J., Friedlos, F., and Boland, M. P. (1993) The bioactivation of CB 1954 and its use as a prodrug in antibody-directed enzyme prodrug therapy (ADEPT). Cancer Metastasis Rev. 12, 195-212
13. Tahara, H. and Lotze, M. T. (1994) Gene therapy for adult cancers: advances in immunologic approaches using cytokines. In Somatic Gene Therapy (Chang, P. L., ed) pp. 263-286, CRC Press, Ann Arbor, Michigan
14. Dilloo, D., Bacon, K., Holden, W., Zhong, W., Burdach, S., Zlotnik, A., and Brenner, M. (1996) Combined chemokine and cytokine gene transfer enhances antitumor immunity. Nature Med. 2, 1090-1095
15. Chen, L., Ashe, S., Brady, W. A., Hellstrom, I., Hellstrom, K. E., Ledbetter, J. A., McGowan, P., and Linsley, P. S. (1992) Costimulation of antitumor immunity by the B7 connterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71, 1093-1102
16. + T cells by B7-transfected melanoma cells. Science 259, 368-370
17. Nabel, G. J., Nabel, E. G., Yang, Z. V., Fox, B. A., Plautz, G. E., Gao, X., Huang, L., Shu, S., Gordon, D., and Chang, A. E. (1993) Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxiciyv in humans. Pror. Natl. Acad. Sci. USA 90, 11307-11311
18. Tepper, R. I., Pattengale, P. K., and Leder, P. (1989) Murine interleukin-1 displays potent anti-tumor activity in vivo. Cell 57, 503-012
19. Colombo, M. P., and Forni, G. (1994) Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now? Immunol. Today 15, 48-51
20. Gansbacher, B., Zier, K., Daniels, B., Cronin, K., Bannerji, R., and Gilboa, E. (1990) Interleukin-2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J. Exp. Med. 172, 1217-1224
21. Hock, H., Dorsch, M., Kunzendorf, U., Uberla, K., Qin, Z., Diamantstein, T., and Blankenstein, T. (1993) Vaccinations with tumor cells genetically engineered to produce different cytokines: Effectivity not superior to a classical adjuvant. Cancer Res. 53, 714-716
22. Papadopoulos, E. B., Ladanyi, M., Emanuel, D., MacKinnon, S., Boulad, F., Carabasi, M. H., Castro-Malaspina, H., Childs, B. H., Gillio, A. P., Small, T. N., Young, J. W., Kernan, N. A., and O'Reilly, R. J. (1994) Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disoallogeneic bone marrow transplantation. N. Engl. J. Med. 330, 1185-1191
23. Brenner, M. K., and Heslop, H. E. (1991) Graft-versus-host reactions and bone marrow transplantation. Curr. Opin. Immunol. 3, 752-757
24. Melief, C. J., and Kast, W. M. (1993) Potential immnnogenicity of oncogene and tumor supressor gene products. Curr. Opin. Immunol. 5, 709-713
25. Rooney, C. M., Smith, C. A., Ng, C., Loftin, S. K., Li, C., Krance, R. A., Brenner, M. K., and Heslop, H. E. (1995) Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliteration. Lancet 345, 9-13
26. Heslop, H. E., Ng, C. Y. C., Li, C., Smith, C. A., Loftin, S. K., Krance, R. A., Brenner, M. K., and Rooney, C. M. (1996) Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nature Med. 2, 551-555
27. Lanzavecchia, A. (1993) Identifying strategies for immune intervention. Science 260, 937-944
28. Rosenberg, S. A. (1992) Gene therapy for cancer. J. Am. Med. Assoc. 268, 2416-2419
29. Murphy, D., Crowther, D., Renninson, J., Prendiville, J., Ranson, M., Lind, M., Patel, U., Dougal, M., Buckley, C. H., and Tindall, V. R. (1993) A randomised dose intensity study in ovarian carcinoma comparing chemotherapy given at four week intervals for six cycles with half dose chemotherapy given for twelve cycles. Ann. Oncol. 4, 377-383
30. Pastan, I., and Gottesman, M. M. (1991) Multidrug resistance. Annu. Rev. Med. 42, 277-291
31. McLachlin, J. R., Eglitis, M. A., Ueda, K., Kantoff, P. W., Pastan, I. H., Anderson, W. F., and Gottesman, M. M. (1990) Expression of a human complementary DNA for the multidrug resistance gene in murine hematopoietic precursor cells with the use of retroviral gene transfer. J. Natl. Cancer Inst. 82, 1260-1263
32. Moritz, T., Mackay, W., Feng, E. J., Samson, L., and Williams, D. A. (1993) Gene transfer of O6-methylguanine methyltransferase (MGMT) protects hematopoietic cells (HC) from nitrosourea (NU) induced toxicity in vitro and in vivo. Blood 82 (Suppl. 1), 118a (abstr.)
33. Brenner, M. K., Rill, D. R., Holladay, M. S., Heslop, H. E., Moen, R. C., Buschle, M., Krance, R. A., Santana, V. M., Anderson, W. F., and Ihle, J. N. (1993) Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342, 1134-1137
34. De Fabritiis, P., Ferrero, D., Sandrelli, A., Tarella, C., Meloni, G., Pulsoni, A., Pregno, P., Badoni, R., DeFelice, L., Gallo, E., Amadori, S., Mandelli, E., and Pileri, A. (1989) Monoclonal antibody purging and autologous bone marrow transplantation in acute myelogenous leukemia in complete remission. Bone Marrow Transpl. 4, 669-674
35. Gribben, J. G., Freedman, A. S., Neuberg, D., Roy, D. C., Blake, K. W., Woo, S. D., Grossbard, M. L., Rabinowe, S. N., Coral, F., Freeman, G. J., Ritz, J., and Nadler, L. M. (1991) Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N. Engl. J. Med. 325, 1525-1533
36. Brenner, M. K., Rill, D. R., Moen, R. C., Krance, R. A., Mirro, J., Jr., Anderson, W. F., and Ihle, J. N. (1993) Gene-marking to trace origin of relapse after autologous bone marrow transplantation. Lancet 341, 85-86
37. + cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 83, 3068-3076
38. Dunbar, C. E., Bodine, D. M., Sorrentino, B., Donahue, R., Cottier-Fox, M., O'Shaughnessy, J., Cowan, K., Carter, C., Doren, S., Cassel, A., and Nienhuis, A. W. (1994) Gene transfer into hematopoietic cells: Implications for cancer therapy. Ann. N.Y. Acad. Sci. 716, 216-224
39. Riddell, S. R., Elliot, M., Lewinsohn, D. A., Gilbert, M. J., Wilson, L., Manley, S. A., Lupton, S. D., Overell, R. W., Reynolds, T. C., Corey, L., and Greenberg, P. D. (1996) T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nature Med. 2, 216-223